文献速递中医内科中药与中成药合理使用

清热除湿汤改善DNCB诱导NC/Nga小鼠特应性皮炎

Qing-Re-Chu-shi decoction ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice through anti-inflammation and immunoregulatory mechanisms.
PubMed 文献 · J Ethnopharmacol · 2024-01-03

研究采用网络药理学与UPLC-质谱分析预测清热除湿汤(Qing-Re-Chu-Shi Decoction, QRCSD)成分与靶点,并在DNCB诱导的NC/Nga小鼠特应性皮炎(AD)样模型中灌胃给药。结果显示QRCSD可减轻皮损、降低血清IgE、调节Th1/Th2平衡,并抑制ERK、P38、JNK、STAT3、P65磷酸化及IL-6表达。

要点

  • QRCSD灌胃可改善AD样皮损、降低表皮厚度与肥大细胞数
  • 可降低血清IgE并上调Claudin 1、Occludin紧密连接蛋白
  • 机制涉及抗炎与免疫调节,抑制MAPK/STAT3/NF-κB通路

核心结论

  • QRCSD通过抗炎与免疫调节机制对特应性皮炎发挥保护作用,可能作为辅助替代治疗的候选方案。

研究设计与样本

  • 研究结合网络药理学与UPLC-质谱分析预测QRCSD活性成分与靶点。
  • 采用DNCB诱导的NC/Nga小鼠AD样模型,QRCSD或泼尼松龙阳性对照自第14天至第21天隔日灌胃。
  • 评估指标包括皮炎严重度评分、搔抓行为、皮肤屏障功能、脾指数、Th1/Th2淋巴细胞比例及血清IgE。
  • 对皮损进行含40种炎症因子的蛋白芯片检测,并用Western blotting在背部皮损验证。

主要发现

  • QRCSD口服可改善AD样皮损,减少表皮厚度与肥大细胞计数,降低血清IgE水平。
  • QRCSD上调紧密连接蛋白Claudin 1与Occludin水平,并调节脾脏Th1/Th2平衡及脾指数。
  • 蛋白芯片显示AD样皮损中IL-4、IL-5、IL-6、IL-17与Eotaxin水平升高。
  • Western blotting证实QRCSD处理后ERK、P38、JNK、STAT3与P65磷酸化水平下调,IL-6表达降低。

关键数值与推荐

  • 网络药理学构建QRCSD-AD网络并进行拓扑分析,提出QRCSD作用于AD的潜在靶点。
  • 蛋白芯片检测覆盖40种炎症因子,用于筛选皮损炎症介质。
  • 以泼尼松龙作为阳性对照,给药方案为隔日灌胃、第14天至第21天。

临床怎么用

  • 本研究为动物实验,QRCSD对人AD的疗效与安全性尚未在此研究中确立。
  • 结果提示QRCSD可能通过多靶点抗炎与免疫调节发挥作用,可供后续临床研究方向参考。

局限性

  • 研究仅基于DNCB诱导的NC/Nga小鼠模型,尚不能直接外推至临床患者。
  • 原文摘要未报告样本量、具体剂量、P值等数据,相关定量结论无法在此呈现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Qing-Re-Chu-Shi Decoction (QRCSD), a traditional Chinese herbal formula, has been employed as a complementary and alternative therapy for inflammatory skin diseases. However, its active constituents and the mechanistic basis of its action on atopic dermatitis remain in adequately understood. AIM OF THE STUDY: Atopic dermatitis (AD) is an allergic dermatitis marked by eczematous lesions and pruritus. The study aimed to elucidate the underlying effects of QRCSD on AD and to identify the components responsible for its therapeutic efficacy in a mouse model. MATERIALS AND METHODS: Network pharmacology and UPLC-mass analysis were used to anticipate the pharmacological mechanisms and to identify active components of QRCSD, respectively. A DNCB-induced AD-like model was established in NC/Nga mice. QRCSD or prednisolone (as a positive control) was administered via gavage every other day from day14 to day 21. Dermatitis severity score, scratching behavior, skin barrier function, spleen index, Th1/Th2 lymphocyte ratio, and serum IgE levels were evaluated. Protein arrays, including 40 inflammatory cytokines, were performed on skin lesions, followed by confirmation experiments of Western blotting in dorsal skin lesions. RESULTS: The construction of a QRCSD-AD-Network and topological analysis firstly proposed potential targets of QRCSD acting on AD. Animal experiments demonstrated that oral administration of QRCSD ameliorated AD-like lesions, reduced epidermal thickness and mast cell count, decreased serum IgE levels, augmented tight junction protein (Claudin 1, Occludin) levels, and regulated the Th1/Th2 balance in the spleen, as well as spleen index. Elevated levels of interleukin (IL)-4, IL-5, IL-6, IL-17, and Eotaxin were revealed in AD-like skin lesions by protein arrays. Western blotting confirmed that the phosphorylation levels of ERK, P38, JNK, STAT3 and P65 were downregulated, and IL-6 expression was also reduced following QRCSD treatment. CONCLUSIONS: The study enhances the understanding of the anti-inflammatory and immunomodulatory effects of QRCSD, showcasing its significant protective role against atopic dermatitis. Treatment with QRCSD may be considered as a viable candidate for complementary and alternative therapy in managing atopic dermatitis.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Meng Y, Liu Y, Guo J, et al. Qing-Re-Chu-shi decoction ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice through anti-inflammation and immunoregulatory mechanisms. J Ethnopharmacol. 2024. PMID: 38176665. doi:10.1016/j.jep.2024.117702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。